Skip to main content
Tenders

Medication Polatuzumab vedotin (Simplified open tender)

Closed
Deadline
0 days left
March 27, 2026
Contract Details
Category
Open Procedure
Reference
6957784
Value
Not disclosed
Location
Kaunas County, Lithuania
Published
March 19, 2026
CPV Code
Project Timeline

Tender Published

March 17, 2026

Deadline for Questions

March 20, 2026

Submission Deadline

March 27, 2026

Tender Opening

March 27, 2026

Win ProbabilityPRO
🔒
Upgrade to Professional
See your estimated win probability based on historical data.
Upgrade to Professional →
Sector InsightsPRO
🔒
Unlock Sector Insights
See average winning prices, competition levels, and market trends.
Upgrade to Professional →
Budget
Not disclosed
Duration
24 months
Location
Kaunas County
Type
Open Procedure
75
Quality Score/100
Good
Market Benchmark
Avg. Winning Price
€50,148
Avg. Bids
7.2
Competition
High
SME Winners
99%
54,649 tenders analyzed

Original Tender Description

Medication Polatuzumab vedotin
Green ProcurementEU Funded

Risk Analysis

Please log in to use risk analysis.

Login

Win Strategy

Please log in to access winning strategy recommendations.

Login

Competitors

Upgrade to see which companies are likely to bid on this tender, based on historical procurement data.

Login

Requirements & Qualifications

AI requirements analysis not yet available for this tender.

Requirements will be generated automatically when tender documents are processed.

Documents

9 documents available with AI summaries

Konkurso sąlygosDOC
Konkurso sąlygos.docx

This document contains the tender conditions for the procurement of the medication Polatuzumab vedotin by the Lithuanian University of Health Sciences Hospital Kauno Klinikos.

Sutarties specialiosios sąlygos_2 priedasDOC
Sutarties specialiosios sąlygos_2 priedas.doc...

This document contains the special conditions for the purchase and sale agreement of the medicinal product Polatuzumab vedotin.

Europos bendrasis viešųjų pirkimų dokumentas (EBVPD)_3 priedasPDF
Europos bendrasis viešųuų pirkimų dokumentas ...

This document is the European Single Procurement Document (ESPD) Annex 3, used for the procurement of the medication Polatuzumab vedotin by the Lithuanian University of Health Sciences Hospital Kaunas Clinics.

NoticePDF
Notice_6957784.pdf

This document contains a tender notice for the procurement of the medication Polatuzumab vedotin by the Lithuanian University of Health Sciences Hospital Kauno Klinikos.

Sutarties bendrosios sąlygosPDF
Sutarties bendrosios sąlygos.pdf

This document contains the general terms and conditions for the purchase and sale of goods, defining key terms and outlining the interpretation and hierarchy of contractual documents for the procurement of the medication Polatuzumab vedotin.

Techninė specifikacijaPDF
Techninė specifikacija.pdf

This document contains the technical specification for the drug Polatuzumab vedotin, outlining requirements for its registration, labeling, and shelf life.

Prekių žiniaraštis_4 priedasXLS
Prekių žiniaraštis_4 priedas.XLS

This document contains a price list for the medication Polatuzumab vedotin, including item number, nomenclature, unit of measure, quantity, and pricing details.

Tender Structure XML - Cycle 1XML
c4t_6957784_1.xml

This document contains the complete tender structure for the Medikamentas Polatuzumab vedotin procurement, requiring a file submission.

Europos bendrasis viešųjų pirkimų dokumentas (EBVPD)_3 priedasXML
Europos bendrasis viešųjų pirkimų dokumentas ...

This document contains a European Single Procurement Document (ESPD) request related to the procurement of the drug Polatuzumab vedotin, specifically addressing exclusion criteria regarding participation in criminal organizations.

Documents Preview

Sign up to view document summaries and analysis

75
Good

Tender Quality Score

This tender for Polatuzumab vedotin is generally well-structured with clear documentation, but lacks specific details on evaluation criteria and financing, impacting practicality and completeness.

Score Breakdown

Legal Compliance75/100

The tender adheres to EU procurement directives (Code: 2014/24/ES) and uses standard forms like the ESPD. The CPV code is appropriate. No disputes are indicated. Deadlines appear reasonable for an open procedure, though the submission deadline is relatively short. The lack of explicit mention of regulatory compliance beyond standard EU directives is a minor point.

Clarity80/100

The title, description, and CPV code are clear. Key documents like technical specifications and contract terms are provided. However, the absence of specified evaluation criteria leaves a significant gap in understanding how bids will be assessed.

Missing evaluation criteria
Completeness70/100

Most basic information is present, including the organization, reference, and contract duration. However, the estimated value is not disclosed, which is a significant omission. While many documents are attached, the lack of explicit financial information and detailed requirements in some sections reduces overall completeness.

Estimated value not disclosed
Fairness85/100

The tender is an open procedure, suggesting broad access. Standard EU procurement documents are used, promoting fairness. There are no immediately apparent requirements tailored to specific companies. The value is not disclosed, which could be a concern for some bidders, but the overall structure is objective.

Practicality65/100

The tender is marked as 'E-Procurement', suggesting electronic submission is possible, but this is not explicitly detailed. The contract start date is not specified. The financing source is indicated as 'EU Funded', but specific financing details or budget allocation are missing. The lack of disclosed value and evaluation criteria also impacts practicality.

No e-submission details
Contract start date not specified
Data Consistency90/100

Key fields like title, reference, organization, and deadlines are populated. The status is 'active', and there are no reported suspensions or disputes. Dates are logical, with an opening date shortly after the submission deadline. The CPV code and NUTS code are present.

Sustainability50/100

The tender is marked as 'EU Funded', which implies adherence to certain EU standards. However, there are no explicit mentions of green procurement, social aspects, or innovation within the provided information, suggesting these are not primary considerations.

No explicit green procurement criteria
No explicit social criteria

Strengths

Clear title and description
Appropriate CPV code
Comprehensive set of required documents (ESPD, technical specs, contract terms)
EU Funded status indicated
Active status with no disputes

Concerns

Estimated value not disclosed
Missing evaluation criteria
Lack of specific e-submission details
No explicit sustainability or innovation focus

Recommendations

1. Disclose the estimated contract value to provide bidders with better context.
2. Clearly define the evaluation criteria to ensure transparency and fairness in the selection process.
3. Provide more specific information regarding the e-submission process and the contract start date.

AI Scoring Preview

Sign up to view complete requirements and analysis

Complete quality score analysis
Detailed sub-score breakdown
Strengths & concerns insights
Strategic recommendations

No credit card required • Setup in 2 minutes

New Service

Want us to handle this tender?

Our procurement experts prepare everything. Proven to work — you review, approve, and submit.

~1hYour time only
80%+80%+
$0Upfront
See full comparison
Without TaaSWith TaaS
40-80 hrs
Preparation time
~1 hr
Your time only
15-25%
Average win rate
80%+
Win rate
Risk of errors
Manual review
Expert QA
Compliance check
You do all
Handle everything
We do all
End-to-end service
Let's Win This Tender
Pay only when you win · 400+ companies trust us
Or do it yourself

Add to Pipeline